STERIS plc (NYSE:STE) Shares Sold by Curi RMB Capital LLC

Curi RMB Capital LLC reduced its stake in STERIS plc (NYSE:STE - Free Report) by 98.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,769 shares of the medical equipment provider's stock after selling 184,280 shares during the period. Curi RMB Capital LLC's holdings in STERIS were worth $775,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Avalon Trust Co acquired a new stake in shares of STERIS during the 4th quarter worth about $30,000. Human Investing LLC purchased a new position in STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC lifted its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC grew its position in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Price Performance

Shares of NYSE:STE traded down $1.35 on Friday, hitting $225.00. The company had a trading volume of 368,819 shares, compared to its average volume of 525,239. The business has a 50 day moving average of $222.89 and a 200 day moving average of $218.95. STERIS plc has a 52-week low of $200.45 and a 52-week high of $248.24. The company has a market cap of $22.11 billion, a PE ratio of 47.77 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS's payout ratio is currently 48.41%.

Wall Street Analyst Weigh In

STE has been the topic of several research reports. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. JMP Securities reaffirmed a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. Finally, Stephens reaffirmed an "overweight" rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, STERIS presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.